TABLE 3.
Oral Anti-diabetic | n | % |
---|---|---|
Metformin | 101 | 39 |
Insulin Secretagogues | 61 | 24 |
Thiazolidinediones | 6 | 2 |
Oral dipeptidyl peptidase 4 inhibitors | 64 | 25 |
Glucagon-like peptide 1 receptor agonists | 2 | 0.7 |
Sodium–Glucose Cotransporter 2 | ||
Inhibitors | 12 | 5 |
Alpha glucosidase inhibitors | 12 | 5 |
% = (n/256).